AU Patent

AU2016204847A1 — Delivery device and method

Assigned to Optinose AS · Expires 2016-07-28 · 10y expired

What this patent protects

Delivery Device and Method The present invention relates to a delivery device for and a method of treating conditions of the nasal airway, in particular inflammatory or infectious conditions relating to the middle meatus.

USPTO Abstract

Delivery Device and Method The present invention relates to a delivery device for and a method of treating conditions of the nasal airway, in particular inflammatory or infectious conditions relating to the middle meatus.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016204847A1
Jurisdiction
AU
Classification
—
Expires
2016-07-28
Drug substance claim
No
Drug product claim
No
Assignee
Optinose AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.